Yan, Chuan http://orcid.org/0000-0002-0449-7072
Do, Daniel
Yang, Qiqi
Brunson, Dalton C.
Rawls, John F.
Langenau, David M. http://orcid.org/0000-0001-6664-8318
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (R01CA215118, R01CA211734, R01CA226926)
the Liddy Shriver Sarcoma InitiativeMGH Research Scholars Program
Alex’s Lemonade Stand Foundation for Childhood Cancer
Tosteson & Fund for Medical Discovery Fellowship from MGH
Article History
Received: 28 May 2019
Accepted: 3 June 2020
First Online: 21 August 2020
Competing interests
: The General Hospital Corporation has a patent pending on the creation and use of immune-compromised zebrafish for engraftment of human cancers. D.M.L. is also a co-inventor on patent application number USSN 14/903,940.